State Update: California’s MUSK Reduction Act to Ban and Restrict Key Fragrance Ingredients

Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Jennifer Porter, BA Psychology, MBA – President & CEO

Having started at Focal Point Research in 2011, Jenn has been fully engaged in the company and since day one, has leveraged her MBA and interest in the regulated products industries to grow her passion for the business and services offered.

Jenn has excelled at building on initial conversations with a variety of companies from all industries seeking regulatory and quality assurance services. She has developed strong relationships with each client, offering each one a unique opportunity to have the Focal Point Research team help them develop successful strategies and bring products to market, while ensuring their compliance needs are being fulfilled.

Jenn has not only been a leader internally, but a key contact for all clients and in 2021, Jenn was the obvious choice to lead Focal Point Research into the future as the successor to company founder, Rob Fichtner.

Jennifer balances her career by honouring her wanderlust, spending her leisure time golfing, and enjoying the outdoors with her loving dog.

California is moving forward with significant new regulations on fragrance ingredients in cosmetic products. Assembly Bill 60, also known as the MUSK Reduction Act, has passed the state legislature and is awaiting the Governor’s signature. The bill targets several synthetic musk components, adding them to the State’s list of prohibited and restricted substances in cosmetics.

Companies with products on the market in California should take note, as the new rules will come into effect on January 1, 2027.

Here is a breakdown of the fragrance ingredients impacted by the bill:

Prohibited Ingredients

Beginning in 2027, the following ingredients will be completely banned from use in cosmetic products sold in California:

musk ambrette (CAS no. 83-66-9)
musk tibetene (CAS no.145-39-1)
musk moskene (CAS no. 116-66-5)
musk xylene (CAS no. 81-15-2)

Restricted Ingredient

The bill also places strict concentration limits on musk ketones, which will vary by product type:

musk ketone (CAS no. 81-14-1)
maximum 1.4% in fine fragrance products
maximum 0.56% in eau de toilette
0% in oral products
0.042% in all other products

Next Steps for the Industry: With a compliance deadline of January 1, 2027, manufacturers and formulators are advised to begin reviewing their product portfolios now. This will allow ample to identify any affected products and undertake necessary reformulations to ensure continued compliance in the California market.

Delsie Braganza

Jennifer Porter, BA Psychology, MBA – President & CEO

State Update: California’s MUSK Reduction Act to Ban and Restrict Key Fragrance Ingredients

Recent Posts

Recent Comments

Archives

Categories